Venture Capital Firms in Cambridge (US)

Atlas Venture is a leading early-stage venture capital firm based in Cambridge, Massachusetts, specializing in the creation and development of biotech companies. The firm partners with scientific entrepreneurs to translate breakthrough innovations into new therapeutic solutions that address unmet medical needs. By combining deep domain expertise with an entrepreneurial approach, Atlas plays a hands-on role in company formation and growth. Since its founding, Atlas has been instrumental in launching and scaling numerous successful biotechnology startups. The firm provides more than capital—it contributes operational guidance, strategic support, and access to a robust network of advisors, co-investors, and industry leaders. This integrated approach has made Atlas a key player in the biotech ecosystem. Atlas Venture maintains a sharp focus on early-stage investing, often co-founding companies from the ground up. Its portfolio includes a broad range of therapeutic areas including oncology, immunology, neurology, and rare diseases. With its base in the biotech hub of Cambridge, the firm is well-positioned to harness cutting-edge research and talent to fuel innovation globally.

F-Prime Capital is a leading global venture capital firm with roots in Fidelity Investments, founded in 1969. The firm specializes in early- to growth-stage investments across various sectors, including healthcare, life sciences, technology, healthtech & services, and cryptocurrency. With over $4.5 billion in assets under management and a portfolio exceeding 300 companies, F-Prime supports visionary entrepreneurs and academics in developing breakthrough innovations that transform medicine and technology worldwide.The firm operates with a stage-agnostic investment approach, backing exceptional teams at any stage from seed to late-stage. Its investment focus within healthcare includes domains such as therapeutics, medtech, health IT, and services, while in the technology sector, it targets enterprise software, fintech, frontier tech, and cryptocurrency. F-Prime combines deep scientific, engineering, and clinical expertise with operational and strategic support to accelerate scalable growth and maximize impact.F-Prime maintains a global presence with offices located in Cambridge (MA), San Francisco, and London. The firm collaborates closely with its sister fund, Eight Roads, to extend its reach across Asia, including countries like China, Japan, India, and Israel, as well as across Europe. F-Prime is recognized for creating or co-creating over 30 companies and actively partners with portfolio ventures to provide critical insights, mentorship, and networking opportunities, fostering innovation with a patient, long-term investment philosophy.

Jefferson Life Sciences is a privately held investment and development firm specializing in life sciences, biotechnology, and healthcare innovation. The company focuses on identifying, funding, and supporting early to mid-stage ventures that address unmet medical needs through cutting-edge research, novel therapeutics, and breakthrough technologies. Its mission is to accelerate scientific innovation from the lab to the patient, with a commitment to long-term value creation. Operating at the intersection of science and capital, Jefferson Life Sciences provides both financial resources and strategic guidance to portfolio companies. Its team of scientific advisors, healthcare experts, and investment professionals collaborates with academic institutions, research labs, and clinical development partners to ensure rigorous evaluation and high-impact outcomes. The firm often takes an active role in shaping the growth strategy of its investments, including commercialization pathways and regulatory navigation. With a growing presence in major biotech hubs such as Boston and San Diego, Jefferson Life Sciences maintains a global outlook, seeking opportunities that align with its mission of improving human health. The firm targets sectors such as oncology, gene therapy, rare diseases, and digital health, aiming to back solutions that not only demonstrate scientific merit but also hold the potential to transform patient care on a global scale.

Matrix Partners is one of the longest‑standing venture capital firms in Silicon Valley, with roots dating back to 1977. The firm specializes in early‑stage investments, backing founders from seed through Series A. Its contrarian investment philosophy emphasizes depth over breadth: instead of indexing every trend, Matrix chooses to partner deeply with a limited number of entrepreneurs who are tackling large, long‑term problems in areas like artificial intelligence, fintech, digital health, cloud infrastructure and SaaS. It manages roughly US$4 billion in assets and has funded more than 400 companies over four decades, including notable successes like Apple, HubSpot, Oculus and F5 Networks. Matrix is known for its hands‑on approach, providing strategic guidance, hiring support and access to a broad network of executives and advisors. While the firm’s main offices are in Palo Alto and Cambridge, it also has a presence in San Francisco and invests in India and China through affiliated funds. Its investment team of around 40 professionals blends former operators, technologists and investors who are passionate about helping founders build enduring companies.